Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Funayama

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Technology in Cancer Research & Treatment|February 27, 2019
Renal Cancer is Not Radioresistant: Slowly but Continuing Shrinkage of the Tumor After Stereotactic Body Radiation TherapySatoshi Funayama, Hiroshi Onishi, Kengo Kuriyama, et al.
Journal of Gastroenterology and Hepatology|February 22, 2023
Effect of a combination of pemafibrate and a mild low-carbohydrate diet on obese and non-obese patients with metabolic-associated fatty liver diseaseYuichiro Suzuki, Shinya Maekawa, Kohji Yamashita, et al.
Journal of Radiation Research|April 18, 2021
Modified Glasgow Prognostic Score is predictive of prognosis for non-small cell lung cancer patients treated with stereotactic body radiation therapy: a retrospective studyZhe Chen, Hotaka Nonaka, Hiroshi Onishi, et al.
Abdominal Radiology (New York)|August 9, 2025
Multi-institutional study for comparison of detectability of hypovascular liver metastases between 70- and 40-keV images: DELMIO studyShintaro Ichikawa, Satoshi Funayama, Tomoko Hyodo, et al.
BMC Pulmonary Medicine|October 8, 2024
Risk factors for relapse of immune-related pneumonitis after 6-week oral prednisolone therapy: a follow-up analysis of a phase II studyMasato Karayama, Naoki Inui, Yusuke Inoue, et al.
Journal for Immunotherapy of Cancer|July 27, 2023
Six-week oral prednisolone therapy for immune-related pneumonitis: a single-arm phase II studyMasato Karayama, Naoki Inui, Yusuke Inoue, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Technology in Cancer Research & Treatment|February 27, 2019
Renal Cancer is Not Radioresistant: Slowly but Continuing Shrinkage of the Tumor After Stereotactic Body Radiation TherapySatoshi Funayama, Hiroshi Onishi, Kengo Kuriyama, et al.
Journal of Gastroenterology and Hepatology|February 22, 2023
Effect of a combination of pemafibrate and a mild low-carbohydrate diet on obese and non-obese patients with metabolic-associated fatty liver diseaseYuichiro Suzuki, Shinya Maekawa, Kohji Yamashita, et al.
Journal of Radiation Research|April 18, 2021
Modified Glasgow Prognostic Score is predictive of prognosis for non-small cell lung cancer patients treated with stereotactic body radiation therapy: a retrospective studyZhe Chen, Hotaka Nonaka, Hiroshi Onishi, et al.
Abdominal Radiology (New York)|August 9, 2025
Multi-institutional study for comparison of detectability of hypovascular liver metastases between 70- and 40-keV images: DELMIO studyShintaro Ichikawa, Satoshi Funayama, Tomoko Hyodo, et al.
BMC Pulmonary Medicine|October 8, 2024
Risk factors for relapse of immune-related pneumonitis after 6-week oral prednisolone therapy: a follow-up analysis of a phase II studyMasato Karayama, Naoki Inui, Yusuke Inoue, et al.
Journal for Immunotherapy of Cancer|July 27, 2023
Six-week oral prednisolone therapy for immune-related pneumonitis: a single-arm phase II studyMasato Karayama, Naoki Inui, Yusuke Inoue, et al.
Pageof 3